US Stock MarketDetailed Quotes

Pacira BioSciences (PCRX)

Watchlist
  • 20.530
  • -0.240-1.16%
Trading Jan 23 12:16 ET
883.23MMarket Cap43.68P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pacira BioSciences (PCRX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
EXPAREL139.9M77.93%
ZILRETTA28.98M16.14%
iovera°6.47M3.60%
Bupivacaine liposome injectable suspension2.69M1.50%
Royalty revenue1.48M0.82%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
US, European Union (E.U.) and United Kingdom (UK)548.96M78.32%
United States118.09M16.85%
U.S., Canada and Europe22.81M3.25%
Bupivacaine liposome injectable suspension7.32M1.04%
Royalty revenue3.78M0.54%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.04%
Sample Name
Sample Code
 +3.99%
Sample Name
Sample Code
 +2.78%
4
Amazon
AMZN
+2.34%
5
NVIDIA
NVDA
+1.71%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.21%
Sample Name
Sample Code
 +9.05%
Sample Name
Sample Code
 +5.17%
4
KE Holdings
BEKE
+4.56%
5
H World Group
HTHT
+3.97%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -